Prognostic nomograms for predicting survival and distant metastases in locally advanced rectal cancers

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Peng, Junjie ^a,b   Ding, Ying ^c   Tu, Shanshan ^d   Shi, Debing ^a,b   Sun, Liang ^e   Li, Xinxiang ^a,b   Wu, Hongbin ^a,b   Cai, Sanjun ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e GEORGIA GWINNETT COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; DISTANT METASTASIS; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OVERALL SURVIVAL; RECTUM CANCER; SURVIVAL PREDICTION; SURVIVAL RATE; TUMOR LOCALIZATION; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECTUM TUMOR; RETROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84940356578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106344     Document Type: Article

References (33)

1. Rahal R, Forte T, Lockwood G, Klein-Geltink J, Bryant H (2012) Recently published indicators allow for comparison of radiation treatment rates relative to evidence-based guidelines for rectal cancer. Current oncology 19: 175-176.
2. Database NC American College of Surgeons Commission on Cancer, 2008 Data Submission.
3. Hyodo I, Suzuki H, Takahashi K, Saito Y, Tanaka S, et al. (2010) Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Japanese journal of clinical oncology 40 Suppl 1: i38-43.
4. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England journal of medicine 351: 1731-1740.
5. Lai LL, Fuller CD, Kachnic LA, Thomas CR Jr (2006) Can pelvic radiotherapy be omitted in select patients with rectal cancer? Seminars in oncology 33: S70-74.
6. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, et al. (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 23: 6199-6206.
7. Tepper JE, O'Connell M, Niedzwiecki D, Hollis DR, Benson AB 3rd, et al. (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control-final report of intergroup 0114. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20: 1744-1750.
8. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) AJCC Cancer Staging Manual (7th Edition). New York: Springer.
9. Green FL, Page DL, Fleming ID, Fritz A, Balch CM, et al. (2002) AJCC Cancer Staging Manual (6th edition). Chicago, IL, American Joint Committee on Cancer.
10. Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, et al. (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. International journal of radiation oncology, biology, physics 72: 99-107.
11. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, et al. (2008) Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 113: 57-64. (Pubitemid 351976386)
12. Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, et al. (2013) Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
13. Meretoja TJ, Strien L, Heikkila PS, Leidenius MH (2012) A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Annals of surgical oncology 19: 567-576.
14. Wang Y, Li J, Xia Y, Gong R, Wang K, et al. (2013) Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31: 1188-1195.
15. Giordano A, Egleston BL, Hajage D, Bland J, Hortobagyi GN, et al. (2013) Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 19: 1596-1602.
16. Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, et al. (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 29: 3163-3172.
17. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in medicine 15: 361-387. (Pubitemid 26072233)
18. Gray R, Barnwell J, McConkey C, Hills RK,Williams NS, et al. (2007) Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 370: 2020-2029.
19. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, et al. (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. The New England journal of medicine 355: 1114-1123. (Pubitemid 44394918)
20. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, et al. (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373: 811-820.
21. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, et al. (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 30: 1926-1933.
22. Canadian Partnership Against Cancer (2011) The 2011 Cancer System Performance Report. Toronto, ON: CPAC.
23. Cho MM, Morgan JW, Knutsen R, Oda K, Shavlik D, et al. (2013) Outcomes of Multimodality Therapies for Patients With Stage II or III Rectal Cancer in California, 1994-2009. Diseases of the colon and rectum 56: 1357-1365.
24. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart A (2010) Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28: 256-263.
25. Ferri M, Lorenzon L, Onelli MR, La Torre M, Mercantini P, et al. (2013) Lymph node ratio is a stronger prognotic factor than microsatellite instability in colorectal cancer patients: Results from a 7 years follow-up study. International journal of surgery.
26. Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, et al. (2013) The Impact of the Lymph Node Ratio is Greater than Traditional Lymph Node Status in Stage III Colorectal Cancer Patients. World journal of surgery 37: 1927-1933.
27. Greenberg R, Itah R, Ghinea R, Sacham-Shmueli E, Inbar R, et al. (2011) Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Techniques in coloproctology 15: 273-279.
28. Peng J, Xu Y, Guan Z, Zhu J, Wang M, et al. (2008) Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Annals of surgical oncology 15: 3118-3123.
29. Petersen SH, Harling H, Kirkeby LT, Wille-Jorgensen P, Mocellin S (2012) Postoperative adjuvant chemotherapy in rectal cancer operated for cure. The Cochrane database of systematic reviews 3: CD004078.
30. Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, et al. (1997) Randomized controlled trial of postoperative radiotherapy and short-term times-cheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. The British journal of surgery 84: 1130-1135. (Pubitemid 27359494)
31. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, et al. (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. Journal of the National Cancer Institute 80: 21-29. (Pubitemid 18076565)
32. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, et al. (1994) The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Annals of surgery 220: 676-682. (Pubitemid 24355781)
33. Lundby L, Krogh K, Jensen VJ, Gandrup P, Qvist N, et al. (2005) Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer. Diseases of the colon and rectum 48: 1343-1349; discussion 1349-1352; author reply 1352.